Overview

Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and effectiveness of an anti-HIV drug regimen followed by treatment interruption in people recently infected with HIV. This study will also compare the effects of a treatment regimen including treatment interruption with a treatment plan based on clinical indicators.
Phase:
N/A
Details
Lead Sponsor:
University of Colorado, Denver
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)
Treatments:
Emtricitabine
Lopinavir
Ritonavir
Tenofovir